US Patent Issued to Abbott Diabetes Care on Oct. 27 for "Method and system for providing integrated analyte monitoring and infusion system therapy management" (Oregon Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,776,405, issued on Oct. 27, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Method and system for providing integrated analyte monitoring and infusion system therapy management" was invented by R. Curtis Jennewine (Portland, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided."

The patent was filed on April 4, 2024, under Application No. 18/627,221.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%...